Accueil
Actualités réglementaires4 sept. 2026•1 min de lecture

Gore VIABAHN® Device Quality Issue Identified

Par l'équipe PharmaCountry

Gore discovered some VIABAHN® devices were processed on equipment outside validated range, risking incorrect distal tip bonding.

Health Canada has issued an alert after Gore identified, through quality‑control testing, that a subset of its VIABAHN® endoprosthesis devices were processed using equipment that was operating outside the validated range. This condition could potentially lead to an incorrect bonding location of the distal tip onto the delivery catheter. Manufacturers and users are advised to review the affected product batches and follow any further guidance from Health Canada regarding corrective actions or product handling.

Compilé par l'équipe PharmaCountry · Source : Health Canada

Plus d'articles

Voir tous les articles